Ottawa hasn’t approached Alberta, Sask., about pharmacare since election: ministers
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $20.00 plus GST for four weeks. After four weeks, your payment will increase to $24.00 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
CALGARY – Alberta and Saskatchewan’s health ministers say they haven’t been approached by Ottawa about signing onto the federal pharmacare program since the spring election.
Saskatchewan Health Minister Jeremy Cockrill says he hasn’t discussed his province’s involvement in the program since former federal minister Mark Holland was in office.
Adriana LaGrange, Alberta’s minister of primary and preventative health services, says she too hasn’t received any indication from Ottawa that it’s still looking to sign more deals.
They were speaking at the end of a meeting of provincial health ministers from across the country in Calgary, ahead of another meeting Friday with federal Health Minister Marjorie Michel.
LaGrange says she expects pharmacare to come up in Friday’s discussion “as an aside.”
Three provinces and one territory have so far have signed onto the program, which sees Ottawa fund coverage for contraceptives and diabetes medication.
Michel’s office says the federal government is monitoring the existing pharmacare deals and is committed to honouring them.
This report by The Canadian Press was first published Oct. 16, 2025.
— By Jack Farrell in Edmonton